Biologic and Immunologic Effects of Knockout of Human Cytomegalovirus Pp65 Nuclear Localization Signal

Overview

Journal Clin Vaccine Immunol

Publisher American Society for Microbiology

Specialties Allergy & Immunology
Pathology

Date 2009 Apr 17

PMID 19369477

Authors

John A Zaia

Xiuli Li

Anne E Franck

Xiwei Wu

Lia Thao

Ghislaine Gallez-Hawkins

Affiliations

Soon will be listed here.

Abstract

The human cytomegalovirus (CMV) pp65 protein contains two bipartite nuclear localization signals (NLSs) at amino acids (aa) 415 to 438 and aa 537 to 561 near the carboxy terminus of CMV pp65 and a phosphate binding site related to kinase activity at lysine-436. A mutation of pp65 with K436N (CMV pp65mII) and further deletion of aa 537 to 561 resulted in a novel protein (pp65mIINLSKO, where NLSKO indicate NLS knockout) that is kinaseless and that has markedly reduced nuclear localization. The purpose of this study was to biologically characterize this protein and its immunogenicity compared to that of native pp65. Unlike the native CMV pp65, following either DNA- or recombinant adeno-associated virus-based transduction of CMV pp65mIINLSKO into cells in vitro, the first observation of pp65mIINLSKO expression was in the cytoplasm and pp65mIINLSKO was expressed at higher levels than the native protein. The CMV pp65mIINLSKO mRNA was more abundant earlier than CMV pp65 mRNA (at 4 h and 8 h, respectively), but the half-lives of the proteins were the same. This modification altered the antigenic processing of CMV pp65 in vitro, as measured by the improved efficiency of cytotoxic killing in a pp65mIINLSKO-transduced human HLA A*0201 target cell line. In HHDII mice expressing HLA A*0201, pp65mIINLSKO was as immunogenic as CMV pp65. By RNA microarray analysis, expression of the CMV pp65mIINLSKO had less of an effect on cell cycle pathways than the native CMV pp65 did and a greater effect on cell surface signaling pathways involving immune activity. It is concluded that the removal of the primary NLS motif from pp65 does not impair its immunogenicity and should be considered in the design of a vaccine.

References

Kalderon D, Roberts B, Richardson W, Smith A . A short amino acid sequence able to specify nuclear location. Cell. 1984; 39(3 Pt 2):499-509. DOI: 10.1016/0092-8674(84)90457-4. View

Khanna R, Diamond D . Human cytomegalovirus vaccine: time to look for alternative options. Trends Mol Med. 2005; 12(1):26-33. DOI: 10.1016/j.molmed.2005.11.006. View

Edgar R, Domrachev M, Lash A . Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2001; 30(1):207-10. PMC: 99122. DOI: 10.1093/nar/30.1.207. View

Diamond D, York J, Sun J, Wright C, Forman S . Development of a candidate HLA A*0201 restricted peptide-based vaccine against human cytomegalovirus infection. Blood. 1997; 90(5):1751-67. View

Luo C, Loros J, Dunlap J . Nuclear localization is required for function of the essential clock protein FRQ. EMBO J. 1998; 17(5):1228-35. PMC: 1170471. DOI: 10.1093/emboj/17.5.1228. View

Lacey S, Diamond D, Zaia J . Assessment of cellular immunity to human cytomegalovirus in recipients of allogeneic stem cell transplants. Biol Blood Marrow Transplant. 2004; 10(7):433-47. DOI: 10.1016/j.bbmt.2003.12.004. View

Elkington R, Walker S, Crough T, Menzies M, Tellam J, Bharadwaj M . Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers. J Virol. 2003; 77(9):5226-40. PMC: 153951. DOI: 10.1128/jvi.77.9.5226-5240.2003. View

Leen A, Myers G, Sili U, Huls M, Weiss H, Leung K . Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals. Nat Med. 2006; 12(10):1160-6. DOI: 10.1038/nm1475. View

Schmolke S, Drescher P, Jahn G, Plachter B . Nuclear targeting of the tegument protein pp65 (UL83) of human cytomegalovirus: an unusual bipartite nuclear localization signal functions with other portions of the protein to mediate its efficient nuclear transport. J Virol. 1995; 69(2):1071-8. PMC: 188678. DOI: 10.1128/JVI.69.2.1071-1078.1995. View

10.

Sylwester A, Mitchell B, Edgar J, Taormina C, Pelte C, Ruchti F . Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J Exp Med. 2005; 202(5):673-85. PMC: 2212883. DOI: 10.1084/jem.20050882. View

11.

Prichard M, Britt W, Daily S, Hartline C, Kern E . Human cytomegalovirus UL97 Kinase is required for the normal intranuclear distribution of pp65 and virion morphogenesis. J Virol. 2005; 79(24):15494-502. PMC: 1316036. DOI: 10.1128/JVI.79.24.15494-15502.2005. View

12.

Berencsi K, Gyulai Z, Gonczol E, Pincus S, Cox W, Michelson S . A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects. J Infect Dis. 2001; 183(8):1171-9. DOI: 10.1086/319680. View

13.

PANDE H, Baak S, Riggs A, Clark B, Shively J, Zaia J . Cloning and physical mapping of a gene fragment coding for a 64-kilodalton major late antigen of human cytomegalovirus. Proc Natl Acad Sci U S A. 1984; 81(15):4965-9. PMC: 391613. DOI: 10.1073/pnas.81.15.4965. View

14.

Sanchez V, Mahr J, Orazio N, Spector D . Nuclear export of the human cytomegalovirus tegument protein pp65 requires cyclin-dependent kinase activity and the Crm1 exporter. J Virol. 2007; 81(21):11730-6. PMC: 2168781. DOI: 10.1128/JVI.02760-06. View

15.

Lomeli N, Li X, Yao Z, La Rosa C, Diamond D, Zaia J . Kinase-deficient CMVpp65 triggers a CMVpp65 specific T-cell immune response in HLA-A*0201.Kb transgenic mice after DNA immunization. Scand J Immunol. 2002; 55(6):592-8. DOI: 10.1046/j.1365-3083.2002.01099.x. View

16.

Rogers S, Wells R, Rechsteiner M . Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science. 1986; 234(4774):364-8. DOI: 10.1126/science.2876518. View

17.

Yao Z, Lomeli N, Li X, Molinder K, Diamond D, Zaia J . Site-directed mutation in a conserved kinase domain of human cytomegalovirus-pp65 with preservation of cytotoxic T lymphocyte targeting. Vaccine. 2001; 19(13-14):1628-35. DOI: 10.1016/s0264-410x(00)00423-0. View

18.

Khan N, Bruton R, Taylor G, Cobbold M, Jones T, Rickinson A . Identification of cytomegalovirus-specific cytotoxic T lymphocytes in vitro is greatly enhanced by the use of recombinant virus lacking the US2 to US11 region or modified vaccinia virus Ankara expressing individual viral genes. J Virol. 2005; 79(5):2869-79. PMC: 548448. DOI: 10.1128/JVI.79.5.2869-2879.2005. View

19.

PANDE H, Forman S, Tanamachi B, Li C, Zaia J, Greenberg P . Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes. J Med Virol. 1994; 43(1):103-10. DOI: 10.1002/jmv.1890430119. View

20.

Abate D, Watanabe S, Mocarski E . Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response. J Virol. 2004; 78(20):10995-1006. PMC: 521853. DOI: 10.1128/JVI.78.20.10995-11006.2004. View